Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Sheraton Philadelphia Downtown Hotel

24 oct 2024 7:30 a.m. - 25 oct 2024 4:10 p.m.

201 North 17th Street, Philadelphia, PA 19103

Real-World Evidence Conference

Translating Insights into Real-World Value

Session 2: Early Development Use Cases

Session Chair(s)

Charles  Lee, MBA, MS

Charles Lee, MBA, MS

Executive Regulatory Science Director

AstraZeneca, United States

Session 2: Early Development Use Cases

Speaker(s)

Ulka B Campbell, PhD

Beyond External Control Arms: Utility of Real-World Data in Oncology Regulatory Applications

Ulka B Campbell, PhD

Aetion Inc, United States

Head of Scientific Strategy

Lisa  Ensign, PhD, MSc

Why and How: An External Control Used to Contextualize the Results of an Early Phase Single Arm Metastatic Pancreatic Study

Lisa Ensign, PhD, MSc

Medidata, a Dassault Systemes Company, United States

VP, Statistics and Regulatory Science Innovation

Representative Invited

Endpoints Optimization for Clinical Trials in Myotonic Dystrophy Type 1 (DM1): A Real World Data-driven Approach

Representative Invited

Sanofi, France

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.